← Leaderboards
Michelle Sang Hsiang
University Of California, San Francisco
$10,232,004
Attributed
$10,232,004
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2012–25$2.5M$1.9M$1.3M$625K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,232,004 · 3
By mechanism
U01$9,574,554 · 2
K23$657,450 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Moses Robert Kamya$27,245,027
- Sam Nsobya$1,244,007
- Rena Chiman Patel$7,764,988
- Melissa D Conrad$2,999,948
- Joseph Derisi$13,950,470
Others in their field
Top investigators on “Detection”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Francis L Halzen · University Of Wisconsin-Madison$243,423,219
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Richard A Gibbs · Baylor College Of Medicine$209,716,260
- Richard K. Wilson · Washington University$206,265,868
- Craig B Thompson · Sloan-Kettering Inst Can Research$156,512,301
Research focus
DetectionPlasmodium FalciparumEffectivenessTransmission ProcessBurden Of IllnessCommunicable DiseasesPharmaceutical PreparationsPrevalenceMalariaInfectionHigh RiskDiagnosticCommunitiesMicroscopyDensityCountryPublic HealthApplied ResearchMissionFollow-UpCost EffectivenessNational Institute Of Allergy And Infectious DiseaseBloodDrug Resistance
Grant awards (14)
Long-term health and socioeconomic impact of interventions targeting low-density malaria infection (LMI) among children in Tanzaniav$1,175,287
U01 · FY2025 · AI · contact PI
Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru$668,530
U01 · FY2025 · AI · contact PI
Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru$577,722
U01 · FY2025 · AI · contact PI
Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru$1,235,767
U01 · FY2024 · AI · contact PI
Long-term health and socioeconomic impact of interventions targeting low-density malaria infection (LMI) among children in Tanzania$1,219,746
U01 · FY2024 · AI · contact PI
Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru$1,261,366
U01 · FY2023 · AI · contact PI
Long-term health and socioeconomic impact of interventions targeting low-density malaria infection (LMI) among children in Tanzania$1,206,533
U01 · FY2023 · AI · contact PI
Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru$1,293,493
U01 · FY2022 · AI · contact PI
Long-term health and socioeconomic impact of interventions targeting low-density malaria infection (LMI) among children in Tanzania$936,110
U01 · FY2022 · AI · contact PI
Evaluating Re-active Surveillance Strategies for Malaria Elimination in Swaziland$131,490
K23 · FY2016 · AI · contact PI
Evaluating Re-active Surveillance Strategies for Malaria Elimination in Swaziland$131,490
K23 · FY2015 · AI · contact PI
Evaluating Re-active Surveillance Strategies for Malaria Elimination in Swaziland$131,490
K23 · FY2014 · AI · contact PI
Evaluating Re-active Surveillance Strategies for Malaria Elimination in Swaziland$131,490
K23 · FY2013 · AI · contact PI
Evaluating Re-active Surveillance Strategies for Malaria Elimination in Swaziland$131,490
K23 · FY2012 · AI · contact PI